Double filtration plasmapheresis in antithyroid drug-refractory Graves disease with a massive goiter
Open Access
- 21 April 2026
- journal article
- Published by The Endocrine Society in JCEM Case Reports
- Vol. 4 (5)
Abstract
We report a case of double filtration plasmapheresis (DFPP) performed in medication-resistant Graves disease (GD) with a massive goiter. A 19-year-old female was diagnosed with GD and initially demonstrated poor medication compliance. She presented with loss of consciousness from hypoxemia due to goiter-related tracheal narrowing. Despite inpatient drug therapy, the thyroid hormone levels remained high. We performed DFPP to control thyrotoxicosis before proceeding with thyroidectomy. After 4 sessions, thyroid hormone levels improved, enabling total thyroidectomy. GD with a large goiter may be refractory to medical therapy. In such cases, DFPP can improve thyroid hormone levels.Keywords
This publication has 16 references indexed in Scilit:
- Selective plasma exchange can reduce auto-antibodies in patients with bullous pemphigoid without affecting factor XIII and fibrinogenJournal of Clinical Apheresis, 2016
- Successful preoperative treatment of a Graves' disease patient with agranulocytosis and hemophagocytosis using double filtration plasmapheresisJournal of Clinical Apheresis, 2011
- HyperthyroidismMedical Science Monitor, 2011
- Comparison of Methimazole and Propylthiouracil in Patients with Hyperthyroidism Caused by Graves’ DiseaseThe Journal of Clinical Endocrinology & Metabolism, 2007
- Antithyroid DrugsNew England Journal of Medicine, 2005
- Therapeutic plasmapheresis in patients with severe hyperthyroidism in whom antithyroid drugs are contraindicatedInternational Journal Of Clinical Practice, 2004
- Response to methimazole in Graves' diseaseClinical Endocrinology, 1995
- A Hyperthyroid Patient with Graves' Disease Who Was Strongly Resistant to Methimazole: Investigation on Possible Mechanisms of the Resistance.Endocrine Journal, 1995
- THE SIGNIFICANCE OF THE INITIAL FT4‐INDEX FOR THE MANAGEMENT OF SINGLE DAILY DOSE METHIMAZOLE TREATMENT OF HYPERTHYROIDISMClinical Endocrinology, 1988
- Opposite Effects of Dexamethasone on Serum Concentrations of 3, 3′,5′-Triiodothyronine (Reverse T3) and 3,3′,5′-Triiodothyronine (T3)The Journal of Clinical Endocrinology & Metabolism, 1975